{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:43:12Z","timestamp":1793187792026,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003053.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000}}],"reference-count":171,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003053.pub6","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T18:51:27Z","timestamp":1511895087000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility"],"prefix":"10.1002","volume":"2018","author":[{"given":"Lara C","family":"Morley","sequence":"first","affiliation":[{"name":"The General Infirmary of Leeds; Department of Obstetrics and Gynaecology; United Leeds Teaching Hospitals NHS Trust Belmont Grove Leeds UK LS2 9NS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tang","sequence":"additional","affiliation":[{"name":"Royal Jubilee Maternity Service; Regional Fertility Centre; Grosvenor Road Belfast UK BT12 6BA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephia","family":"Yasmin","sequence":"additional","affiliation":[{"name":"University College Hospital; 2nd floor North, 250 Euston Road London UK NW1 2PG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Norman","sequence":"additional","affiliation":[{"name":"University of Adelaide; Obstetrics & Gynaecology, Robinson Institute; Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam H","family":"Balen","sequence":"additional","affiliation":[{"name":"The Leeds Centre for Reproductive Medicine, Seacroft Hospital; Reproductive Medicine and Surgery; York Road Leeds UK LS14 6UH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"10.1002\/14651858.CD003053.pub6-BIB0001|cit1","first-page":"199","article-title":"Efficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS)","volume":"6","author":"Ayaz","year":"2013","journal-title":"Journal of Medicine and Life"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0974-1208.112372","article-title":"Metformin-clomiphene citrate vs. clomiphene citrate alone: polycystic ovarian syndrome","volume":"6","author":"Ayaz","year":"2013","journal-title":"Journal of Human Reproductive Sciences"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3329\/bjog.v29i1.30438","article-title":"Effect of metformin and clomiphene citrate in improving fertility in subfertility women with polycystic ovary syndrome: a randomised controlled trial","volume":"29","author":"Begum","year":"2014","journal-title":"Bangladesh Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0005|cit5","first-page":"43","article-title":"Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome","volume":"87","author":"Ben Ayed","year":"2009","journal-title":"Tunisie Medicale"},{"issue":"5","key":"10.1002\/14651858.CD003053.pub6-BIB0006|cit6","first-page":"335","article-title":"Indication of metformin in the management of hormonal dysfunction secondary to polycystic ovarian syndrome: prospective comparative study of 63 cases.","volume":"88","author":"Boudhr\u00e2a","year":"2010","journal-title":"Tunisie Medicale"},{"issue":"4","key":"10.1002\/14651858.CD003053.pub6-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/jc.2008-2156","article-title":"Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment","volume":"94","author":"Aigner","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0008|cit8","first-page":"3835","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ajog.2004.05.030","article-title":"Does metformin induce ovulation in normoandrogenic anovulatory women?","volume":"191","author":"Carmina","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2003-39056","article-title":"Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial","volume":"35","author":"Chou","year":"2003","journal-title":"Hormone and Metabolic Research"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2005-1994","article-title":"Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial","volume":"91","author":"Eisenhardt","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0012|cit12","first-page":"43","article-title":"The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome","volume":"6","author":"El-Biely","year":"2001","journal-title":"Middle East Fertility Society Journal"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0014|cit14","unstructured":"Fleming R Hopkinson ZE Wallace E Greer IA Sattar N Metformin treatment improves ovulation frequency in women with oligomenorrhoea: a randomized, double blind placebo trial Human Fertility 2000 389 90"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0015|cit15","first-page":"151","article-title":"Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial","volume":"7","author":"Gerli","year":"2003","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD003053.pub6-BIB0016|cit16","first-page":"347","article-title":"Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS","volume":"11","author":"Gerli","year":"2007","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2265.2007.03015.x","article-title":"Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome","volume":"68","author":"Glintborg","year":"2008","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fertnstert.2005.12.067","article-title":"Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome","volume":"86","author":"Glintborg","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/dc07-1424","article-title":"Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment","volume":"31","author":"Glintborg","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1210\/jc.2005-0615","article-title":"Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome","volume":"90","author":"Glintborg","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2005.04.004","article-title":"Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome","volume":"90","author":"Hwu","year":"2005","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0023|cit23","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"S359","key":"10.1002\/14651858.CD003053.pub6-BIB0025|cit24","first-page":"P","article-title":"Metabolic risks of the lean PCOS woman","volume":"100","author":"Kar","year":"2013","journal-title":"Fertility and Sterility ASRM abstracts"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0024|cit25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0974-1208.170373","article-title":"Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: a randomized controlled trial","volume":"8","author":"Kar","year":"2015","journal-title":"Journal of Human Reproductive Science"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0026|cit26","first-page":"174","article-title":"The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome","volume":"12","author":"Karimzadeh","year":"2007","journal-title":"Middle East Fertility Society Journal"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.fertnstert.2009.02.078","article-title":"An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome","volume":"94","author":"Karimzadeh","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.fertnstert.2005.10.042","article-title":"Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome","volume":"85","author":"Khorram","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.fertnstert.2011.05.085","article-title":"The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome - a double-blind randomized placebo-controlled study","volume":"96","author":"Lam","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD003053.pub6-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1210\/jc.2008-0287","article-title":"Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome","volume":"93","author":"Cataldo","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial","volume":"113","author":"Lord","year":"2006","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0033|cit33","first-page":"27","article-title":"Evaluation of the use of metformin for ovulation in patients with PCOS resistant to isolated use of clomiphene citrate","volume":"16","author":"Machado","year":"2012","journal-title":"Brazilian Journal Assisted Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","article-title":"Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin","volume":"81","author":"Maciel","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD003053.pub6-BIB0035|cit35","first-page":"663","article-title":"The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome","volume":"23","author":"Malkawi","year":"2002","journal-title":"Saudi Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0036|cit36","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD003053.pub6-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/den182","article-title":"Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?","volume":"23","author":"Moll","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/humrep\/des310","article-title":"Health-related quality of life in women with newly diagnosed polycystic ovary syndrome randomized between clomifene citrate plus metformin or clomifene citrate plus placebo","volume":"27","author":"Moll","year":"2012","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"26","key":"10.1002\/14651858.CD003053.pub6-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD003053.pub6-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome","volume":"340","author":"Nestler","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003053.pub6-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/humrep\/16.8.1625","article-title":"Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial","volume":"16","author":"Ng","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2005.05.010","article-title":"Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?","volume":"123","author":"Onalan","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/09513590903215581","article-title":"Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial","volume":"26","author":"Otta","year":"2010","journal-title":"Gynecological Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD003053.pub6-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","article-title":"Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome","volume":"90","author":"Palomba","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.fertnstert.2006.05.035","article-title":"Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome","volume":"86","author":"Palomba","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0048|cit48","first-page":"61","article-title":"Metformin improves insulin, body fat distribution, and androgens in obese women with and without the polycystic ovary syndrome","volume":"21 Suppl 2","author":"Casimirri","year":"1997","journal-title":"International Journal of Obesity"},{"issue":"8","key":"10.1002\/14651858.CD003053.pub6-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1479-828X.2011.01295.x","article-title":"Analysis of factors predicting success of metformin and clomiphene treatment for women with infertility owing to PCOS-related ovulation dysfunction in a randomised controlled trial","volume":"51","author":"Johnson","year":"2011","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD003053.pub6-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/humrep\/deq100","article-title":"PCOSMIC: a multi-centre randomized trial in women with Polycystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene","volume":"25","author":"Johnson","year":"2010","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/humrep\/dei505","article-title":"Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study","volume":"21","author":"Rautio","year":"2006","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.fertnstert.2006.05.061","article-title":"Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study","volume":"87","author":"Rautio","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD003053.pub6-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.fertnstert.2009.01.114","article-title":"Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial","volume":"93","author":"Romualdi","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejogrb.2003.09.036","article-title":"The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome","volume":"113","author":"Sahin","year":"2004","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"4","key":"10.1002\/14651858.CD003053.pub6-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10815-009-9304-z","article-title":"Evaluating the equivalence of clomiphene citrate with and without metformin in ovulation induction in PCOS patients","volume":"26","author":"Siebert","year":"2009","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"5","key":"10.1002\/14651858.CD003053.pub6-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2125.2002.01575.x","article-title":"Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice","volume":"53","author":"Sturrock","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Human Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD003053.pub6-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/humrep\/dem271","article-title":"Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial","volume":"22","author":"Trolle","year":"2007","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.ogx.0000300471.31456.ea","article-title":"Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial","volume":"63","author":"Trolle","year":"2008","journal-title":"Obstetrics and Gynecological Survey"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2009.07.1076","article-title":"A randomized, placebo-controlled study of the influence of instant-release metformin on response to clomiphene citrate and time to conception in polycystic ovary syndrome","volume":"92 Suppl","author":"Williams","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humrep\/17.2.289","article-title":"Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial","volume":"17","author":"Yarali","year":"2002","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0015-0282(01)02126-4","article-title":"Co-administration of metformin during recombinant follicle stimulating hormone (recombinant FSH) treatment using the low-dose step protocol in patients with clomiphene citrate resistant polycystic ovary syndrome (PCOS): a prospective randomized trial","volume":"76 Suppl","author":"Yarali","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.fertnstert.2007.12.002","article-title":"Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial","volume":"91","author":"Zain","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mefs.2013.05.002","article-title":"Clomiphene citrate alone, in combination with metformin or in combination with pioglitazone as first line therapy in induction of ovulation in infertile women with polycystic ovary syndrome, a randomised controlled trial","volume":"18","author":"Abuelghar","year":"2013","journal-title":"Middle East Fertility Society Journal"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1210\/jc.2008-1133","article-title":"Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial","volume":"94","author":"Aroda","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD003053.pub6-BIB0068|cit68","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jclinepi.2003.10.018","article-title":"Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated","volume":"57","author":"Guyatt","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1210\/jc.2003-030044","article-title":"Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone","volume":"88","author":"Legro","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)04914-2","article-title":"Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome","volume":"79","author":"Azziz","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0072|cit72","first-page":"574","article-title":"Comparison between pioglitazone and metformin in terms of efficacy in patients with polycystic ovarian syndrome","volume":"10","author":"Chaudhry","year":"2016","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"issue":"10","key":"10.1002\/14651858.CD003053.pub6-BIB0073|cit73","first-page":"643","article-title":"Does metformin augment the ovulation inducing effects of clomiphene in non-obese women with polycystic ovary syndrome?","volume":"106","author":"Chaudhury","year":"2008","journal-title":"Journal of the Indian Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0074|cit74","first-page":"105","article-title":"Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial","volume":"13","author":"Costantino","year":"2009","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"7","key":"10.1002\/14651858.CD003053.pub6-BIB0075|cit75","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women","volume":"80","author":"Crave","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/09513590.2011.583957","article-title":"Metformin versus lifestyle changes in treating women with polycystic ovary syndrome","volume":"28","author":"Curi","year":"2010","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","article-title":"Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome","volume":"72","author":"Leo","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD003053.pub6-BIB0078|cit78","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD003053.pub6-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3923\/jms.2006.765.771","article-title":"Metformin-therapy effects in 50 clomiphene citrate resistant PCOS patients","volume":"6","author":"Farzadi","year":"2006","journal-title":"Journal of Medical Science"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0081|cit81","unstructured":"Heathcote G Forbes K Lee A Gregor M Luscombe G Boothroyd C Live birth rate after metformin and clomiphene vs clomiphene alone in polycystic ovary syndrome (PCOS): a randomized, double-blind, placebo-controlled trial Draft paper supplied by authors"},{"issue":"8","key":"10.1002\/14651858.CD003053.pub6-BIB0082|cit82","first-page":"589","article-title":"Study on treatment of hyperandrogenism and hyperinsulinism in polycystic ovary syndrome with Chinese herbal formula \"tiangui fang\"","volume":"20","author":"Hou","year":"2000","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"6","key":"10.1002\/14651858.CD003053.pub6-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1210\/jcem.87.6.8568","article-title":"Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation","volume":"87","author":"Ibanez","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijgo.2009.04.022","article-title":"Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome","volume":"107","author":"Kazerooni","year":"2009","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.0.1470217","article-title":"The effect of metformin on hirsutism in polycystic ovary syndrome","volume":"147","author":"Kelly","year":"2002","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0015-0282(01)02941-7","article-title":"Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome","volume":"77","author":"Kocak","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2010.12.002","article-title":"The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0088|cit88","first-page":"299","article-title":"Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome","volume":"66","author":"Leanza","year":"2014","journal-title":"Minerva Ginecologica"},{"issue":"6","key":"10.1002\/14651858.CD003053.pub6-BIB0089|cit89","first-page":"1687","article-title":"Leptin concentrations in the polycystic ovary syndrome","volume":"82","author":"Mantzoros","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD003053.pub6-BIB0090|cit90","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0091|cit91","first-page":"i67","article-title":"Metformin improves pregnancy and live birth rates in women with polycystic ovary syndrome - a multicentre placebo-controlled randomised trial","volume":"25","author":"Morin-Papunen","year":"2010","journal-title":"26th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE Rome Italy"},{"issue":"9","key":"10.1002\/14651858.CD003053.pub6-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003053.pub6-BIB0093|cit93","first-page":"4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens","volume":"82","author":"Nestler","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.fertnstert.2011.08.020","article-title":"Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial","volume":"96","author":"Palomba","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.fertnstert.2008.01.088","article-title":"Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"91","author":"Papaleo","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0096|cit96","first-page":"143","article-title":"The use of metformin in overweight and lean infertile patients with polycystic ovarian syndrome: a randomised controlled trial","volume":"8","author":"Ramzy","year":"2003","journal-title":"Middle East Fertility Society Journal"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0097|cit97","first-page":"142","article-title":"Characteristics of polycystic ovary syndrome with and without insulin resistance and the role of insulin sensitizing drug (metformin) in its management","volume":"10","author":"Refaie","year":"2005","journal-title":"Middle East Fertility Society Jounal"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.fertnstert.2005.07.1312","article-title":"A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome","volume":"85","author":"Rouzi","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"Supplement 3","key":"10.1002\/14651858.CD003053.pub6-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.fertnstert.2014.07.475","article-title":"Insulin sensitizing agent (metformin) improves clinical pregnancy rate in clomiphene citrate resistant polycystic ovarian syndrome patients with acanthosis nigricans","volume":"102","author":"Salman","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"11-12","key":"10.1002\/14651858.CD003053.pub6-BIB0100|cit100","first-page":"455","article-title":"Comparison between clomiphene citrate and metformin for induction of ovulatory cycles in infertile nonobese women with polycystic ovary syndrome","volume":"31","author":"Santonocito","year":"2009","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1071-55760200260-5","article-title":"Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy","volume":"10","author":"Shobokshi","year":"2003","journal-title":"Journal of the Society for Gynecologic Investigation"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0102|cit102","first-page":"452","article-title":"Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"15","author":"Unfer","year":"2011","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.rbmo.2015.09.015","article-title":"Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?","volume":"32","author":"Abu Hashim","year":"2016","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12020-014-0182-5","article-title":"Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria","volume":"47","author":"Alebi\u0107","year":"2014","journal-title":"Endocrine"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0108|cit108","doi-asserted-by":"crossref","DOI":"10.1201\/b16081","volume-title":"Infertility in Practice","author":"Balen","year":"2014"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0110|cit110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009090.pub2","article-title":"Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome","author":"Bordewijk","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/humupd\/dmu022","article-title":"First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis","volume":"20","author":"Cassina","year":"2014","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000107291.46159.00","article-title":"Maternal morbid obesity and the risk of adverse pregnancy outcome","volume":"103","author":"Cedergren","year":"2004","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.fertnstert.2013.12.050","article-title":"Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study","volume":"101","author":"Celik","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"Epub ahead of p","DOI":"10.1371\/journal.pone.0061551","article-title":"Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins","volume":"8","author":"Colca","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome","volume":"79","author":"Costello","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005552.pub2","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"Costello","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/humrep\/deu154","article-title":"A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome","volume":"29","author":"Fr\u00e8ne","year":"2014","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0118|cit118","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-09-0733","article-title":"Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome","volume":"162","author":"Diamanti-Kandarakis","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0121|cit121","unstructured":"European Medicines Agency European Medicines Agency clarifies opinion on pioglitazone and the risk of bladder cancer www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2011\/10\/news_detail_001368.jsp&mid=WC0b01ac058004d5c1&jsenabled=true Accessed 2011"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"The Thessaloniki ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0125|cit125","unstructured":"FDA (Federal Drug Administration) www.fda.gov"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2003.12.022","article-title":"The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study","volume":"173","author":"Ford","year":"2004","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD003053.pub6-BIB0127|cit127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010287.pub2","article-title":"Aromatase inhibitors for subfertile women with polycystic ovary syndrome","author":"Franik","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0129|cit129","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(02)01529-2","article-title":"Troglitazone-induced liver failure: a case study","volume":"114","author":"Graham","year":"2003","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2007-967093","article-title":"Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome","volume":"115","author":"Hahn","year":"2007","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0133|cit133","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0134|cit134","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07435800.2014.966385","article-title":"Short-term intervention with liraglutide improved eating behaviour in obese women with polycystic ovary syndrome","volume":"40","author":"Jensterle","year":"2014","journal-title":"Endocrine Research"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"9593","key":"10.1002\/14651858.CD003053.pub6-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials","volume":"370","author":"Lago","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0139|cit139","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fertnstert.2006.04.010","article-title":"Type 2 diabetes and polycystic ovary syndrome","volume":"86 Suppl 1","author":"Legro","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD003053.pub6-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.fertnstert.2006.03.037","article-title":"The Pregnancy in Polycystic Ovary Syndrome Study: baseline characteristics of the randomized cohort including racial effects","volume":"86","author":"Legro","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/1464727022000198952","article-title":"Polycystic ovary syndrome and fat distribution: the central issue?","volume":"5","author":"Lord","year":"2002","journal-title":"Hum Fertil (Camb)"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dms036","article-title":"Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"19","author":"Misso","year":"2013","journal-title":"Human Reproduction Update"},{"issue":"7","key":"10.1002\/14651858.CD003053.pub6-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007506.pub3","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/humrep\/des114","article-title":"Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome","volume":"27","author":"Moran","year":"2012","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.2008.03369.x","article-title":"Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis","volume":"70","author":"Palomba","year":"2009","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmg024","article-title":"Obesity and reproductive disorders in women","volume":"9","author":"Pasquali","year":"2003","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin--mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/humrep\/dei505","article-title":"Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study","volume":"21","author":"Rautio","year":"2006","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD003053.pub6-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.fertnstert.2006.05.061","article-title":"Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study","volume":"87","author":"Rautio","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0152|cit152","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","article-title":"The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries","volume":"39","author":"Robinson","year":"1993","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0154|cit154","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0155|cit155","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013 Available from guidelinedevelopment.org\/handbook"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000335253","article-title":"Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis","volume":"73","author":"Siebert","year":"2012","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"5","key":"10.1002\/14651858.CD003053.pub6-BIB0157|cit157","first-page":"1389","article-title":"Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome","volume":"88","author":"Soares","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0160|cit160","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention . Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"11","key":"10.1002\/14651858.CD003053.pub6-BIB0161|cit161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006105.pub3","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","author":"Tso","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S0007114500001070","article-title":"The Finnish Diabetes Prevention Study","volume":"83 Suppl 1","author":"Uusitupa","year":"2000","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclicity after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Velazquez","year":"1997","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09513590701214158","article-title":"Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria","volume":"23","author":"Weerakiet","year":"2007","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02019.x","article-title":"Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?","volume":"60","author":"Wijeyaratne","year":"2004","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003053.pub6-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.apsb.2012.06.010","article-title":"Mitochondrial inhibitor as a new class of insulin sensitizer","volume":"2","author":"Zhang","year":"2012","journal-title":"Acta Pharmacologica Sinica"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","author":"Lord","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003053.pub6-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053.pub4","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003053.pub6-BIB0171|cit171","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053.pub5","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003053.pub6\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T01:19:47Z","timestamp":1719623987000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003053.pub6"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":171,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003053.pub6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732188124.793559360","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]}}}